Literature DB >> 6497102

Antimicrobial susceptibility of coagulase-positive staphylococci isolated from Louisiana dogs.

H U Cox, J D Hoskins, A F Roy, S S Newman, D G Luther.   

Abstract

Disk diffusion susceptibility tests were done on 1,178 clinical strains of coagulase-positive staphylococci (CPS) isolated from dogs during a 7-year period. Relative decreases of 7% to 33% were found in the percentages of CPS sensitive to 8 antimicrobics. Relative percentages of CPS sensitive to 9 other antimicrobics were increased or decreased less than 5%. Sensitivity to the beta-lactam antibiotics showed the least relative change. Regression analysis demonstrated that the greatest change in percentage sensitivity of CPS occurred to gentamicin and cephalothin and the least change occurred to penicillin and ampicillin. Recent canine clinical isolates of CPS, specifically identified as Staphylococcus intermedius (n = 109), were uniformly sensitive to novobiocin, amikacin, tobramycin, spectinomycin, and amoxicillin-clavulanic acid. Twenty-two isolates were also sensitive to 17 other antimicrobics. Eighty-seven isolates were resistant to 1 or more antimicrobics tested. Resistance was most common to sulfonamides, penicillin G, ampicillin, tetracycline, and streptomycin. Differences in susceptibility results between S intermedius and unspecified CPS were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497102

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.

Authors:  D W Scott; K E Beningo; W H Miller; E Rothstein
Journal:  Can Vet J       Date:  1998-12       Impact factor: 1.008

2.  Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen.

Authors:  D A Talan; D Staatz; A Staatz; E J Goldstein; K Singer; G D Overturf
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Antimicrobial susceptibility and rRNA gene restriction patterns among Staphylococcus intermedius from healthy dogs and from dogs suffering from pyoderma or otitis externa.

Authors:  K Pedersen; H C Wegener
Journal:  Acta Vet Scand       Date:  1995       Impact factor: 1.695

4.  Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs.

Authors:  D W Scott; W H Miller; S M Cayatte; M S Bagladi
Journal:  Can Vet J       Date:  1994-10       Impact factor: 1.008

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.